Publication | Closed Access

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)

OncologyPancreatic CancerGastrointestinal OncologyMedicinePharmacotherapyCancer TreatmentAdjuvant TherapyPharmacologyRadiation Oncology